Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. CRSP
CRSP logo

CRSP

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

CRSP News

Analysis of CRISPR Therapeutics' Prospects

18h agoFool

New CRISPR Technology Opens Opportunities in Biotech

2h agoNASDAQ.COM

New CRISPR Technology Could Transform Market Dynamics

3h agoFool

Investment Outlook on Genetic Engineering and Weight Loss Innovations

22h agoFool

Comparative Investment in Gene Editing and Metabolic Medicine

2d agoFool

Investment Outlook for CRISPR and Viking Therapeutics

2d agoNASDAQ.COM

FDA Expands Approval for Casgevy Gene Therapy to Younger Patients

5d agostocktwits

Analysis of ARKK ETF's 52-Week Price Fluctuations

5d agoNASDAQ.COM

Investment Comparison Between CRISPR and Vertex

Jun 27 2026Fool

Investment Comparison: CRISPR vs. Vertex Pharmaceuticals

Jun 27 2026NASDAQ.COM

Investment Opportunities in the Healthcare Sector

Jun 22 2026Fool

CRISPR Therapeutics Faces Commercialization Challenges

Jun 18 2026Fool

CRISPR Therapeutics Faces Market Challenges Amid Progress

Jun 18 2026NASDAQ.COM

Biotech Sector Thrives with Strong Growth Potential

Jun 17 2026Fool

Investment Opportunities in Biotech Stocks

Jun 17 2026NASDAQ.COM

Investment Portfolio Strategy Analysis

Jun 17 2026Fool